Kyoto, Japan

Yoshio Arakawa

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshio Arakawa. Retrieved from https://idiyas.com/inventor/yoshio-arakawa-i5ssn0hs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Yoshio Arakawa

Introduction

Yoshio Arakawa is a notable inventor hailing from Kyoto, Japan, known for his contributions to the field of chemistry, specifically concerning reverse hydroxamic acid derivatives. With a unique understanding of chemical compounds and their applications, he has made significant strides in pharmaceutical research.

Latest Patents

Arakawa holds a patent for reverse hydroxamic acid derivatives, which are characterized by a specific structure represented by general formulas (Ia) and (I). These compounds are designed to target Tumor Necrosis Factor-alpha converting enzyme (TACE) inhibitory activity, showcasing his innovative approach to addressing health-related challenges through chemical solutions.

Career Highlights

Yoshio Arakawa works at Kaken Pharmaceutical Company, Ltd., where his research has significantly impacted pharmaceutical development. His work emphasizes the intersection of chemistry and medicine, contributing to advancements in therapeutic agents.

Collaborations

Throughout his career, Arakawa has collaborated with esteemed coworkers, including Masanao Shimano and Noriyuki Kamei. Their teamwork exemplifies the collaborative spirit often found in research institutions, fostering an environment conducive to innovation and discovery.

Conclusion

Yoshio Arakawa's journey as an inventor underscores the importance of innovation in the pharmaceutical industry. His patent on reverse hydroxamic acid derivatives is a testament to his dedication to enhancing medical technology and offers promising avenues for further research and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…